LRMR
Price
$3.68
Change
+$0.02 (+0.55%)
Updated
Nov 25, 10:41 AM (EDT)
Capitalization
312.83M
113 days until earnings call
Intraday BUY SELL Signals
OLMA
Price
$25.49
Change
+$0.44 (+1.76%)
Updated
Nov 25, 10:38 AM (EDT)
Capitalization
1.97B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LRMR vs OLMA

Header iconLRMR vs OLMA Comparison
Open Charts LRMR vs OLMABanner chart's image
Larimar Therapeutics
Price$3.68
Change+$0.02 (+0.55%)
Volume$1.82K
Capitalization312.83M
Olema Pharmaceuticals
Price$25.49
Change+$0.44 (+1.76%)
Volume$4.37K
Capitalization1.97B
LRMR vs OLMA Comparison Chart in %
LRMR
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LRMR vs. OLMA commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a StrongBuy and OLMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (LRMR: $3.65 vs. OLMA: $25.05)
Brand notoriety: LRMR and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 17% vs. OLMA: 136%
Market capitalization -- LRMR: $312.83M vs. OLMA: $1.97B
LRMR [@Biotechnology] is valued at $312.83M. OLMA’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 0 green, 5 red.
According to our system of comparison, both LRMR and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 6 TA indicator(s) are bullish while OLMA’s TA Score has 6 bullish TA indicator(s).

  • LRMR’s TA Score: 6 bullish, 4 bearish.
  • OLMA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both LRMR and OLMA are a good buy in the short-term.

Price Growth

LRMR (@Biotechnology) experienced а +3.54% price change this week, while OLMA (@Biotechnology) price change was +194.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.70%. For the same industry, the average monthly price growth was -1.72%, and the average quarterly price growth was +68.09%.

Reported Earning Dates

LRMR is expected to report earnings on Mar 18, 2026.

OLMA is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+2.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($1.97B) has a higher market cap than LRMR($313M). OLMA YTD gains are higher at: 329.674 vs. LRMR (-5.556). LRMR has higher annual earnings (EBITDA): -108.21M vs. OLMA (-156.66M). OLMA has more cash in the bank: 362M vs. LRMR (139M). LRMR (4.61M) and OLMA (4.76M) have identical debt. LRMR (0) and OLMA (0) have equivalent revenues.
LRMROLMALRMR / OLMA
Capitalization313M1.97B16%
EBITDA-108.21M-156.66M69%
Gain YTD-5.556329.674-2%
P/E RatioN/AN/A-
Revenue00-
Total Cash139M362M38%
Total Debt4.61M4.76M97%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LRMROLMA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFANX14.07N/A
N/A
Fidelity Asset Manager 40%
PIUCX23.67N/A
N/A
Federated Hermes International Equity C
IGIIX42.43N/A
N/A
Macquarie Global Growth Fund Class I
FPCGX28.62N/A
N/A
Fort Pitt Capital Total Return
FSGGX18.16N/A
N/A
Fidelity Global ex US Index

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with VNDA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+8.11%
VNDA - OLMA
38%
Loosely correlated
+1.87%
ORMP - OLMA
37%
Loosely correlated
+0.39%
VERA - OLMA
36%
Loosely correlated
+2.74%
NUVL - OLMA
34%
Loosely correlated
+3.48%
LRMR - OLMA
33%
Poorly correlated
+2.67%
More